Ideaya Biosciences Inc
IDYA
Market Cap$2.91B
Close$
$-0.09
100.3% downside
Current Fair Value
100.3% downsideOvervalued by 100.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.91 Billion |
|---|---|
| Enterprise Value | $2.21 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.01 |
| Beta | 1.23 |
| Outstanding Shares | 75,686,628 |
| Avg 30 Day Volume | 701,024 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -22.58 |
|---|---|
| PEG | -33.5 |
| Price to Sales | - |
| Price to Book Ratio | 2.98 |
| Enterprise Value to Revenue | 142.78 |
| Enterprise Value to EBIT | -13.91 |
| Enterprise Value to Net Income | -18 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ideaya Biosciences Inc
CEO: Yujiro Hata